1. OP0086 Long-term efficacy and safety of adalimumab by immunosuppressant use in patients with non-infectious uveitis in the visual iii trial. (12th June 2018) Authors: Guex-Crosier, Y.; Foster, C.S.; Nakai, K.; Goto, H.; Douglas, K.; Pathai, S.; Kron, M.; Song, A.P.; Van Calster, J.; Adán, A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0523 Adalimumab in Patients with Active, Non-Infectious Uveitis Requiring High-Dose Corticosteroids: the Visual-1 Trial. (9th June 2015) Authors: Jaffe, G.J.; Thorne, J.E.; Scales, D.; Franco, P.J.; Tari, S.; Camez, A.; Song, A.P.; Kron, M.; Barisani-Asenbauer, T.; Dick, A.D. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 849 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0561 Adalimumab in Patients with Active and Inactive, Non-Infectious Uveitis: Visual I and Visual II Trials. (15th July 2016) Authors: Brézin, A.P.; Dick, A.D.; Jaffe, G.J.; Ohno, S.; Namba, K.; Goto, H.; Inomata, N.; Song, A.P.; Kron, M.; Camez, A.; Tari, S.; Nguyen, Q.D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗